home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  May 28, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 461 active entries

Wantai Biological Pharmacy Enterprice Co.,Ltd

Chuangxin Road No7, Changping District

Phone: 0086-10-89705848
Fax: 0086-10-89705849

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Welcome to Wantai Biological Pharmacy Enterprise Co., Ltd

The official supplier of HIV blood screening reagents in China.
The Chinese market-leader in the IVD reagents for infectious diseases.

13 years of experiences
Strong R&D abilities
Integrated technical and customer-oriented marketing support
Year- by-Year excellent financial status and prospective future
Reliable social and business partners

Founded in 1991 and developed from a small laboratory, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (hereunder called Wantai), is a private company, invested by Yangshengtang Group- a famous Chinese Pharmaceutical, mineral water and health care product holding company. Wantai locates about 30km. North of Beijing and is focused on the research, development, production and commercialization of IVD products and vaccines. Wantai is the first IVD manufacturer in China with quality management systems and manufacturing facilities certified from SFDA China with GMP certificate in 2002.
Our research and marketing efforts extend to the fields of clinical testing, disease control and prevention, blood screening etc.

ELISA kits for diagnosis and screening of infectious diseases
Rapid colloidal gold chromatographic tests
Recombinant vaccines

Most of our ELISA test kits are batch-released by the National Institute for the Control of Pharmaceutical and Biological Products (NICPBP) before market release.

Our clients are:

Blood banks
Research and specialized laboratories
State health organizations
Reference State centers

In collaboration with scientific institutions and companies in China and the world, we have brought several unique products to the market:
HIV 1+2 ELISA - The first China-made double antigen “sandwich” assay, the current domestic market leader in the field of blood supply safety
HIV 1+2 rapid Test – The first China-made HIV Rapid Test
HTLV 1+2 ELISA - double antigen ”sandwich” assay
anti-TP ELISA - double antigen ”sandwich” assay
hepatitis E IgM ELISA – antibody capture assay

Our key partners include: State Laboratory for Tumor Cell Engineer of Xiamen University, Microbiology Department of Hong Kong University., etc.

Selected Categories:

Product Company   Service Company
- Immunoassay
- in vitro

Last update of this entry: September 19, 2010

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.